C4 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.98 M | $25.12 M | 5.68% | 10.02% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 6.85 M | $24.67 M | -0.40% | 9.84% |
| WASATCH ADVISORS LP | 02/13/2025 | 6.07 M | $21.86 M | 6.96% | 8.72% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.56 M | $20.01 M | 13.66% | 7.98% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.88 M | $17.56 M | 0.00% | 7.01% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 4.38 M | $15.76 M | 0.00% | 6.29% |
| VANGUARD GROUP INC | 02/11/2025 | 3.35 M | $12.05 M | -0.73% | 4.81% |
| SAMLYN CAPITAL, LLC | 02/14/2025 | 3.02 M | $10.87 M | 100.00% | 4.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.55 M | $5.58 M | 198.08% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.38 M | $4.97 M | 0.83% | 1.98% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 1.33 M | $4.80 M | 1.11% | 1.92% |
| STATE STREET CORP | 02/14/2025 | 1.22 M | $4.40 M | -56.43% | 1.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.22 M | $4.40 M | 6.38% | 1.75% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 1.11 M | $4.00 M | 0.00% | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 900,000 | $3.24 M | 28.57% | 1.29% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 884,300 | $3.18 M | -17.01% | 1.27% |
| UBS GROUP AG | 02/14/2025 | 757,852 | $2.73 M | 126.85% | 1.09% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 573,655 | $2.07 M | 13.40% | 0.82% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 563,837 | $2.03 M | -31.94% | 0.81% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 523,931 | $1.89 M | -9.49% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 486,366 | $1.75 M | 0.71% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 360,125 | $1.30 M | 1,548.32% | 0.52% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 283,705 | $1.02 M | -0.82% | 0.41% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 227,147 | $817,729 | 18.08% | 0.33% |
| FMR LLC | 02/13/2025 | 218,365 | $786,114 | 17.44% | 0.31% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 200,000 | $720,000 | 100.00% | 0.29% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 196,466 | $707,277 | -83.65% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 192,424 | $692,727 | 6.40% | 0.28% |
| MARINER, LLC | 02/13/2025 | 167,975 | $604,710 | 28.80% | 0.24% |
| SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 155,000 | $558,000 | 100.00% | 0.22% |
| JANE STREET GROUP, LLC | 02/14/2025 | 152,774 | $549,987 | 119.97% | 0.22% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 150,000 | $540,000 | 0.00% | 0.22% |
| CITIGROUP INC | 02/12/2025 | 144,300 | $519,480 | 477.20% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 141,083 | $507,900 | -1.54% | 0.20% |
| UBS OCONNOR LLC | 02/14/2025 | 137,360 | $494,496 | 497.22% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 132,832 | $478,195 | 8.55% | 0.19% |
| M&T BANK CORP | 02/06/2025 | 132,715 | $478,079 | 16.51% | 0.19% |
| BARCLAYS PLC | 02/13/2025 | 122,365 | $441,000 | -49.74% | 0.18% |
| WEXFORD CAPITAL LP | 02/14/2025 | 118,331 | $425,992 | 114.25% | 0.17% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 109,825 | $395,371 | 6.60% | 0.16% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 108,664 | $391,190 | 100.00% | 0.16% |
| ATOM INVESTORS LP | 02/14/2025 | 101,684 | $366,062 | 100.00% | 0.15% |
| RHUMBLINE ADVISERS | 01/30/2025 | 100,015 | $360,049 | 4.56% | 0.14% |
| VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP | 02/10/2025 | 85,000 | $306,000 | 0.00% | 0.12% |
| 02/14/2025 | 80,100 | $288,360 | 100.00% | 0.12% | |
| D. E. SHAW & CO., INC. | 02/14/2025 | 76,479 | $275,324 | -35.67% | 0.11% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 69,628 | $250,661 | 100.00% | 0.10% |
| INVESCO LTD. | 02/13/2025 | 69,193 | $249,095 | 7.20% | 0.10% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 59,654 | $215,000 | 100.00% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 58,376 | $210,154 | -43.85% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
C4 Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 144 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:
Soleus Capital Management, L.P.: 6.98 M
Lynx1 Capital Management LP: 6.85 M
WASATCH ADVISORS LP: 6.07 M
BlackRock Funding, Inc. /DE: 5.56 M
RA CAPITAL MANAGEMENT, L.P.: 4.88 M
ORBIMED ADVISORS LLC: 4.38 M
92.49% of C4 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 68.58 M shares in the last 24 months. This purchase volume represents approximately $280.48 M in transactions.